Oxford Nanopore Technologies Denmark ApS
Private limited companyCVR 41747978HellerupActive
Oxford Nanopore Technologies Denmark ApS is a private limited company, based in Hellerup, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2020. Net profit rose 53% from 2024 to 2025, ending at DKK 314k. Equity grew to DKK 1m in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 27% (2024 → 2025), to DKK 5.8m.
- Net profit rose 53% (2024 → 2025), to DKK 314k.
- Equity rose 45% (2024 → 2025), to DKK 1m.
Management and owners, last 24 months
- New in management: Francis Van Parys (director, 02/03/2025) and Nicholas Patrick Keher (ceo, 15/09/2025).
- Stepped down: Timothy Cowper (ceo, 15/09/2025).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2021–2025 · amounts in DKK thousandEquity and net profit
| 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 2,113 | 2,107 | 5,686 | 4,567 | 5,792 | +26.8% |
| Operating profit (EBIT) | – | 126 | 340 | 246 | 354 | +44.2% |
| Profit before tax | 126 | 119 | 350 | 270 | 372 | +38.2% |
| Net profit | 97 | 90 | 273 | 205 | 314 | +53% |
| Total assets | 1,101 | 958 | 2,014 | 1,697 | 1,871 | +10.2% |
| Equity | 137 | 228 | 500 | 705 | 1,019 | +44.5% |
| Liabilities | 964 | 730 | 1,514 | 992 | 851 | −14.2% |
| Cash and cash equivalents | 381 | 93 | 1,037 | 1,049 | 607 | −42.2% |
| Average number of employees | 1 | 2 | 3 | 4 | 5 | +25% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresProfit for five years in a row
Net result has been positive in 2021–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
5 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 28/05/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 30/06/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 26/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 29/06/2023 | The company | PDFXBRL |
| 2021 | 29/09/2020 – 31/12/2021 | 23/06/2022 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 11,186of 69,742 Better than 84% | No. 33,427of 69,964 Better than 52% |
| Same industry and fewer than 20 employees150 companies in the comparison | No. 62of 150 Better than 59% | No. 108of 150 Better than 28% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 7,577of 33,588 Better than 77% | No. 15,315of 33,687 Better than 55% |
| All companies of type ApS66,508 companies in the comparison | No. 11,801of 66,379 Better than 82% | No. 29,310of 66,505 Better than 56% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- Oxford Nanopore Technologies Denmark ApSDKK 5.8m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Oxford Nanopore Technologies Denmark ApSDKK 314k
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- Oxford Nanopore Technologies Denmark ApSDKK 1m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- Oxford Nanopore Technologies Denmark ApS5
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Oxford Nanopore Technologies Holdings Limited100%
Management
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Francis Van Parys | Director | 02/03/2025 |
| Nicholas Patrick Keher | CEO | 15/09/2025 |
- Founders
- Oxford Nanopore Technologies PLC
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Timothy Cowper | CEO | 29/09/2020 | 15/09/2025 |
Signing rule: Selskabet tegnes af et medlem af direktionen alene.
Address and production units
1 active production unitsRygårds Allé 104
2900 Hellerup
København Municipality · Postcode 2900
Other companies at the address (8)
- AA Euro Contracting ApSBusiness and other management consultancy activities
- HB Leisure Denmark ApSOther sports activities n.e.c.
- Horizons Global Technology ApSBusiness and other management consultancy activities
- Omega Wind ApSInstallation of industrial machinery and equipment
- Nutanix Denmark ApSWholesale of information and communication equipment
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Oxford Nanopore Technologies Denmark ApS | Rygårds Allé 104, 2900 Hellerup | 5 | 1026349148 |
Purpose
Selskabets formål er at handle med produkter udviklet af Oxford Nanopore Technologies, købe og sælge kapitalandele i virksomheder og andre investeringsaktiver som ejendomme samt hermed beslægtet virksomhed.
The purpose is quoted from the register in Danish.
Changes year by year
13 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20254 changesmanagement 3 · accounts 1
- ManagementNicholas Patrick Keher appointed ceo
- ManagementTimothy Cowper stepped down as ceo
- AccountsAnnual report for 2024 published
- ManagementFrancis Van Parys appointed director
20243 changesownership 2 · accounts 1
- OwnershipOxford Nanopore Technologies Holdings Limited registered as owner (100%)
- OwnershipOxford Nanopore Technologies PLC is no longer registered as owner
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20221 changeaccounts 1
- AccountsAnnual report for 2021 published
20203 changesfounded 1 · management 1 · ownership 1
- FoundedRegistered as Oxford Nanopore Technologies Denmark ApS
- ManagementTimothy Cowper appointed ceo
- OwnershipOxford Nanopore Technologies PLC registered as owner (100%)
Related companies
Same industry in København
- Nomeco A/S939 employees
- Abacus Medicine A/S388 employees
- Novo Nordisk Denmark A/S300 employees
- Msd Danmark ApS132 employees
- Astrazeneca A/S122 employees
- Sandoz A/S118 employees
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.